nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—CYP2C9—brain cancer	0.659	1	CbGaD
Dexfenfluramine—CYP2D6—Lomustine—brain cancer	0.0748	0.282	CbGbCtD
Dexfenfluramine—CYP1A2—Carmustine—brain cancer	0.074	0.279	CbGbCtD
Dexfenfluramine—CYP2D6—Hydroxyurea—brain cancer	0.0567	0.214	CbGbCtD
Dexfenfluramine—CYP2E1—Etoposide—brain cancer	0.0379	0.143	CbGbCtD
Dexfenfluramine—CYP1A2—Etoposide—brain cancer	0.0219	0.0827	CbGbCtD
Dexfenfluramine—HTR2C—choroid plexus—brain cancer	0.0122	0.296	CbGeAlD
Dexfenfluramine—HTR2C—telencephalic ventricle—brain cancer	0.00357	0.0867	CbGeAlD
Dexfenfluramine—HTR2C—ganglion—brain cancer	0.00222	0.054	CbGeAlD
Dexfenfluramine—SLC6A4—ganglion—brain cancer	0.00211	0.0512	CbGeAlD
Dexfenfluramine—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00179	0.0524	CbGpPWpGaD
Dexfenfluramine—SLC6A4—hindbrain—brain cancer	0.0016	0.0388	CbGeAlD
Dexfenfluramine—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00142	0.0414	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00141	0.0412	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00128	0.0375	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Synaptic Vesicle Pathway—SYP—brain cancer	0.00122	0.0357	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.00111	0.0325	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0011	0.0321	CbGpPWpGaD
Dexfenfluramine—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00109	0.032	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00107	0.0312	CbGpPWpGaD
Dexfenfluramine—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00101	0.0294	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.001	0.0292	CbGpPWpGaD
Dexfenfluramine—HTR2C—brainstem—brain cancer	0.000966	0.0235	CbGeAlD
Dexfenfluramine—SLC6A4—brainstem—brain cancer	0.000916	0.0223	CbGeAlD
Dexfenfluramine—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000879	0.0257	CbGpPWpGaD
Dexfenfluramine—HTR2C—telencephalon—brain cancer	0.000857	0.0208	CbGeAlD
Dexfenfluramine—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000845	0.0247	CbGpPWpGaD
Dexfenfluramine—SLC6A4—telencephalon—brain cancer	0.000813	0.0197	CbGeAlD
Dexfenfluramine—HTR2B—telencephalon—brain cancer	0.000805	0.0196	CbGeAlD
Dexfenfluramine—CYP2D6—hindbrain—brain cancer	0.00077	0.0187	CbGeAlD
Dexfenfluramine—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000764	0.0223	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000678	0.0198	CbGpPWpGaD
Dexfenfluramine—HTR2C—medulla oblongata—brain cancer	0.000674	0.0164	CbGeAlD
Dexfenfluramine—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000652	0.0191	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000624	0.0182	CbGpPWpGaD
Dexfenfluramine—HTR2C—midbrain—brain cancer	0.000616	0.015	CbGeAlD
Dexfenfluramine—HTR2C—spinal cord—brain cancer	0.000601	0.0146	CbGeAlD
Dexfenfluramine—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.0006	0.0175	CbGpPWpGaD
Dexfenfluramine—SLC6A4—midbrain—brain cancer	0.000584	0.0142	CbGeAlD
Dexfenfluramine—CYP2A6—cerebellum—brain cancer	0.000582	0.0141	CbGeAlD
Dexfenfluramine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000575	0.0168	CbGpPWpGaD
Dexfenfluramine—SLC6A4—spinal cord—brain cancer	0.000569	0.0138	CbGeAlD
Dexfenfluramine—HTR2C—head—brain cancer	0.000534	0.013	CbGeAlD
Dexfenfluramine—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000528	0.0154	CbGpPWpGaD
Dexfenfluramine—SLC6A4—endocrine gland—brain cancer	0.000513	0.0125	CbGeAlD
Dexfenfluramine—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000508	0.0148	CbGpPWpGaD
Dexfenfluramine—SLC6A4—head—brain cancer	0.000506	0.0123	CbGeAlD
Dexfenfluramine—HTR2B—head—brain cancer	0.000501	0.0122	CbGeAlD
Dexfenfluramine—CYP2E1—telencephalon—brain cancer	0.000495	0.012	CbGeAlD
Dexfenfluramine—HTR2C—central nervous system—brain cancer	0.000487	0.0118	CbGeAlD
Dexfenfluramine—CYP2A6—brain—brain cancer	0.000472	0.0115	CbGeAlD
Dexfenfluramine—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000466	0.0136	CbGpPWpGaD
Dexfenfluramine—SLC6A4—central nervous system—brain cancer	0.000462	0.0112	CbGeAlD
Dexfenfluramine—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000462	0.0135	CbGpPWpGaD
Dexfenfluramine—HTR2B—central nervous system—brain cancer	0.000458	0.0111	CbGeAlD
Dexfenfluramine—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000456	0.0133	CbGpPWpGaD
Dexfenfluramine—CYP2D6—brainstem—brain cancer	0.000441	0.0107	CbGeAlD
Dexfenfluramine—CYP2C19—endocrine gland—brain cancer	0.000425	0.0103	CbGeAlD
Dexfenfluramine—CYP2D6—telencephalon—brain cancer	0.000392	0.00952	CbGeAlD
Dexfenfluramine—CYP2E1—medulla oblongata—brain cancer	0.000389	0.00945	CbGeAlD
Dexfenfluramine—HTR2C—brain—brain cancer	0.000387	0.0094	CbGeAlD
Dexfenfluramine—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000374	0.0109	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000367	0.0107	CbGpPWpGaD
Dexfenfluramine—SLC6A4—brain—brain cancer	0.000367	0.00891	CbGeAlD
Dexfenfluramine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000365	0.0107	CbGpPWpGaD
Dexfenfluramine—HTR2B—brain—brain cancer	0.000363	0.00883	CbGeAlD
Dexfenfluramine—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00036	0.0105	CbGpPWpGaD
Dexfenfluramine—CYP1A2—endocrine gland—brain cancer	0.000347	0.00843	CbGeAlD
Dexfenfluramine—CYP2E1—spinal cord—brain cancer	0.000347	0.00842	CbGeAlD
Dexfenfluramine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000346	0.0101	CbGpPWpGaD
Dexfenfluramine—CYP2C9—endocrine gland—brain cancer	0.000329	0.008	CbGeAlD
Dexfenfluramine—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000326	0.00952	CbGpPWpGaD
Dexfenfluramine—CYP2E1—endocrine gland—brain cancer	0.000312	0.00758	CbGeAlD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—NTRK3—brain cancer	0.00031	0.00904	CbGpPWpGaD
Dexfenfluramine—CYP2E1—head—brain cancer	0.000308	0.00749	CbGeAlD
Dexfenfluramine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000296	0.00864	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000282	0.00823	CbGpPWpGaD
Dexfenfluramine—CYP2E1—central nervous system—brain cancer	0.000281	0.00683	CbGeAlD
Dexfenfluramine—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000278	0.00812	CbGpPWpGaD
Dexfenfluramine—CYP2E1—cerebellum—brain cancer	0.000275	0.00668	CbGeAlD
Dexfenfluramine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000259	0.00757	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000256	0.00747	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000254	0.00742	CbGpPWpGaD
Dexfenfluramine—CYP2D6—endocrine gland—brain cancer	0.000247	0.006	CbGeAlD
Dexfenfluramine—CYP2D6—head—brain cancer	0.000244	0.00593	CbGeAlD
Dexfenfluramine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000228	0.00667	CbGpPWpGaD
Dexfenfluramine—CYP2E1—brain—brain cancer	0.000223	0.00543	CbGeAlD
Dexfenfluramine—CYP2D6—central nervous system—brain cancer	0.000223	0.00541	CbGeAlD
Dexfenfluramine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000219	0.00641	CbGpPWpGaD
Dexfenfluramine—CYP2D6—cerebellum—brain cancer	0.000218	0.00529	CbGeAlD
Dexfenfluramine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000217	0.00633	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000211	0.00616	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00021	0.00613	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000199	0.00581	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000178	0.0052	CbGpPWpGaD
Dexfenfluramine—CYP2D6—brain—brain cancer	0.000177	0.0043	CbGeAlD
Dexfenfluramine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000157	0.00459	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000156	0.00457	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000155	0.00453	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—PTCH2—brain cancer	0.000142	0.00415	CbGpPWpGaD
Dexfenfluramine—HTR2B—G alpha (q) signalling events—TRPC6—brain cancer	0.00014	0.00409	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000125	0.00366	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—OR14C36—brain cancer	0.000125	0.00364	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—OR4C12—brain cancer	0.000125	0.00364	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—HES1—brain cancer	0.000121	0.00355	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000121	0.00354	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.00012	0.00349	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000117	0.00342	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—PTCH2—brain cancer	0.000115	0.00335	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—OR14C36—brain cancer	0.000113	0.00331	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—OR4C12—brain cancer	0.000113	0.00331	CbGpPWpGaD
Dexfenfluramine—HTR2C—G alpha (q) signalling events—TRPC6—brain cancer	0.000113	0.0033	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000112	0.00326	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.00011	0.00321	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—SIRT1—brain cancer	0.000103	0.003	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—brain cancer	0.000101	0.00295	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—OR4C12—brain cancer	0.000101	0.00294	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—OR14C36—brain cancer	0.000101	0.00294	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	9.75e-05	0.00285	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	9.45e-05	0.00276	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	9.32e-05	0.00272	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—OR14C36—brain cancer	9.13e-05	0.00267	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—OR4C12—brain cancer	9.13e-05	0.00267	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	8.93e-05	0.00261	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—CDK4—brain cancer	7.77e-05	0.00227	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—SHH—brain cancer	7.32e-05	0.00214	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PTCH2—brain cancer	7.29e-05	0.00213	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—PTCH1—brain cancer	6.94e-05	0.00203	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR ligand binding—SMO—brain cancer	6.94e-05	0.00203	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—OR4C12—brain cancer	6.69e-05	0.00195	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—OR14C36—brain cancer	6.69e-05	0.00195	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—ABR—brain cancer	6.3e-05	0.00184	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	6.09e-05	0.00178	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—SHH—brain cancer	5.91e-05	0.00173	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PTCH2—brain cancer	5.88e-05	0.00172	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—ABR—brain cancer	5.72e-05	0.00167	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DTX2—brain cancer	5.69e-05	0.00166	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	5.62e-05	0.00164	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—SMO—brain cancer	5.6e-05	0.00164	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR ligand binding—PTCH1—brain cancer	5.6e-05	0.00164	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—OR14C36—brain cancer	5.39e-05	0.00158	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—OR4C12—brain cancer	5.39e-05	0.00158	CbGpPWpGaD
Dexfenfluramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—brain cancer	5.36e-05	0.00157	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—ABR—brain cancer	5.08e-05	0.00149	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	5.06e-05	0.00148	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.66e-05	0.00136	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—ABR—brain cancer	4.62e-05	0.00135	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DTX2—brain cancer	4.59e-05	0.00134	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTCH2—brain cancer	4.31e-05	0.00126	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	4.3e-05	0.00126	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HES5—brain cancer	4.17e-05	0.00122	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STRADA—brain cancer	4.05e-05	0.00118	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—TRPC6—brain cancer	3.99e-05	0.00117	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.96e-05	0.00116	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.87e-05	0.00113	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.87e-05	0.00113	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—SHH—brain cancer	3.76e-05	0.0011	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.63e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—TRPC6—brain cancer	3.62e-05	0.00106	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—SMO—brain cancer	3.56e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PTCH1—brain cancer	3.56e-05	0.00104	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTCH2—brain cancer	3.48e-05	0.00102	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.4e-05	0.000995	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CYP2C9—brain cancer	3.4e-05	0.000994	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ABR—brain cancer	3.38e-05	0.000988	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HES5—brain cancer	3.37e-05	0.000983	CbGpPWpGaD
Dexfenfluramine—SLC6A4—Circadian rythm related genes—TP53—brain cancer	3.31e-05	0.000966	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STRADA—brain cancer	3.27e-05	0.000955	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GLI2—brain cancer	3.27e-05	0.000954	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—TRPC6—brain cancer	3.22e-05	0.00094	CbGpPWpGaD
Dexfenfluramine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.21e-05	0.000936	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.1e-05	0.000907	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GLI1—brain cancer	3.07e-05	0.000897	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—SHH—brain cancer	3.03e-05	0.000885	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—VAV1—brain cancer	2.99e-05	0.000873	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—TRPC6—brain cancer	2.92e-05	0.000854	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SUFU—brain cancer	2.91e-05	0.00085	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—BSG—brain cancer	2.89e-05	0.000845	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PTCH1—brain cancer	2.87e-05	0.000839	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—SMO—brain cancer	2.87e-05	0.000839	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—GFAP—brain cancer	2.81e-05	0.00082	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ABR—brain cancer	2.73e-05	0.000797	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—VAV1—brain cancer	2.71e-05	0.000793	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.69e-05	0.000785	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HEY1—brain cancer	2.66e-05	0.000778	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.65e-05	0.000775	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GLI2—brain cancer	2.63e-05	0.00077	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—DLL1—brain cancer	2.61e-05	0.000763	CbGpPWpGaD
Dexfenfluramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	2.59e-05	0.000755	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—IDH1—brain cancer	2.49e-05	0.000726	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GLI1—brain cancer	2.48e-05	0.000723	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—VAV1—brain cancer	2.41e-05	0.000704	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SUFU—brain cancer	2.35e-05	0.000686	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—BSG—brain cancer	2.29e-05	0.000668	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—GFAP—brain cancer	2.27e-05	0.000662	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SHH—brain cancer	2.22e-05	0.000648	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—VAV1—brain cancer	2.19e-05	0.00064	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HEY1—brain cancer	2.15e-05	0.000627	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TRPC6—brain cancer	2.14e-05	0.000625	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—DLL1—brain cancer	2.11e-05	0.000615	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PTCH1—brain cancer	2.1e-05	0.000615	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SMO—brain cancer	2.1e-05	0.000615	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP2C9—brain cancer	2.07e-05	0.000606	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ENO2—brain cancer	1.97e-05	0.000574	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—IDH1—brain cancer	1.97e-05	0.000574	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.91e-05	0.000557	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	1.9e-05	0.000554	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SHH—brain cancer	1.79e-05	0.000523	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—BSG—brain cancer	1.76e-05	0.000515	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TRPC6—brain cancer	1.73e-05	0.000504	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	1.72e-05	0.000503	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SMO—brain cancer	1.7e-05	0.000496	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PTCH1—brain cancer	1.7e-05	0.000496	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOTCH2—brain cancer	1.68e-05	0.000491	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—BSG—brain cancer	1.62e-05	0.000474	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.62e-05	0.000472	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—BSG—brain cancer	1.61e-05	0.00047	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VAV1—brain cancer	1.6e-05	0.000468	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ENO2—brain cancer	1.55e-05	0.000454	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—PIK3CG—brain cancer	1.53e-05	0.000447	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—IDH1—brain cancer	1.52e-05	0.000443	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—IDH1—brain cancer	1.39e-05	0.000407	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—PIK3CG—brain cancer	1.39e-05	0.000406	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—IDH1—brain cancer	1.38e-05	0.000404	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—HES1—brain cancer	1.38e-05	0.000403	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—BSG—brain cancer	1.37e-05	0.000401	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOTCH2—brain cancer	1.36e-05	0.000396	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.34e-05	0.00039	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.31e-05	0.000384	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VAV1—brain cancer	1.29e-05	0.000378	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SPP1—brain cancer	1.27e-05	0.000372	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.23e-05	0.000361	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL2—brain cancer	1.21e-05	0.000354	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ENO2—brain cancer	1.2e-05	0.00035	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—IDH1—brain cancer	1.18e-05	0.000345	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IRS2—brain cancer	1.15e-05	0.000337	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.13e-05	0.000329	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HES1—brain cancer	1.11e-05	0.000325	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ENO2—brain cancer	1.1e-05	0.000322	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ENO2—brain cancer	1.09e-05	0.000319	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—IL2—brain cancer	1.08e-05	0.000315	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	1.06e-05	0.000309	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SPP1—brain cancer	1.03e-05	0.0003	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—APC—brain cancer	1.02e-05	0.000297	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.02e-05	0.000297	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL2—brain cancer	9.79e-06	0.000286	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.62e-06	0.000281	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ENO2—brain cancer	9.34e-06	0.000273	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IRS2—brain cancer	9.3e-06	0.000272	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EGFR—brain cancer	9.28e-06	0.000271	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3CG—brain cancer	9.02e-06	0.000263	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APC—brain cancer	8.21e-06	0.00024	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	8.21e-06	0.00024	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RELA—brain cancer	7.96e-06	0.000232	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—ERBB2—brain cancer	7.91e-06	0.000231	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—brain cancer	7.48e-06	0.000219	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL2—brain cancer	7.17e-06	0.000209	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3CG—brain cancer	7.13e-06	0.000208	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCND1—brain cancer	6.99e-06	0.000204	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	6.92e-06	0.000202	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RELA—brain cancer	6.42e-06	0.000187	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—ERBB2—brain cancer	6.38e-06	0.000186	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—brain cancer	6.09e-06	0.000178	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—STAT3—brain cancer	6.03e-06	0.000176	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL2—brain cancer	5.78e-06	0.000169	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCND1—brain cancer	5.64e-06	0.000165	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MYC—brain cancer	5.6e-06	0.000164	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	5.58e-06	0.000163	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3CG—brain cancer	5.5e-06	0.000161	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—brain cancer	5.48e-06	0.00016	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3CG—brain cancer	5.06e-06	0.000148	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3CG—brain cancer	5.01e-06	0.000146	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—brain cancer	4.91e-06	0.000144	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—STAT3—brain cancer	4.86e-06	0.000142	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TP53—brain cancer	4.6e-06	0.000134	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MYC—brain cancer	4.52e-06	0.000132	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—brain cancer	4.42e-06	0.000129	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3CG—brain cancer	4.28e-06	0.000125	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TP53—brain cancer	3.71e-06	0.000108	CbGpPWpGaD
